Hutch News

Hutch News

Stories tagged 'immunocompromised patients'

What we can learn about global flu evolution from individual infections

Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends

June 27, 2017 | By Rachel Tompa / Fred Hutch News Service

When it comes to the flu, a few infected people may speak for the multitude. Evolutionary biologists have found that evolution in individual infections has parallels to the virus's later global evolution.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 22, 2016

Dr. Candice Grzelak gets $180K to study breast cancer mets; Infectious Disease Sciences earns training grant; Drs. Jesse Bloom, Frederick "Erick" Matsen named HHMI-Simons Faculty Scholars

View story >


How the SCCA successfully suppressed pandemic flu

Aggressive infection-control program protected Seattle Cancer Care Alliance patients from acquiring clinic-based H1N1 influenza

Dec. 21, 2009 | By Dean Forbes

According to a study by the Fred Hutchinson Cancer Research Center, aggressive infection-control and screening measures at the Seattle Cancer Care Alliance during the spring 2009 H1N1 influenza epimedic protected immunocompromised cancer patients from the flu. While the Seattle area had a 100-fold increase in H1N1 cases, there was no corresponding increase among the patient population.

View story >


Mayor helps open SCCA House

When the new Seattle Cancer Care Alliance-owned facility opens Sept. 28, it will help fill the demand for temporary lodging for cancer patients and their caregivers

Sept. 21, 2009 | By Dean Forbes

When the SCCA House officially opens at the end of the month, patients will enter a facility carefully monitored for people with some degree of immunosuppression.

View story >


Tobias Hohl: Helping the immune system fight fungus

New VIDI investigator tracks down the cells and molecules used by human immune system to battle invasive fungal infections to improve care for immunocompromised patients

Aug. 24, 2009

Dr. Tobias Hohl came to the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Institute in May with a mission: to track down the cells and molecules used by human immune system to battle invasive fungal infections, in an effort to improve care for immunocompromised patients who contract fungal diseases. Hohl's win of a Young Investigator Award from the American Society for Microbiology in July underscores his progress in a challenging field—challenging because, compared to bacterial and viral pathogens, fungal diseases are understudied and difficult to diagnose and treat.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.